Inoperable Stage III EGFR Mutant Non-Small Cell Lung Cancer: time for drug first, local later? John A, McDonald F, Popat S. Ann Oncol 2024 Oct 10:S0923-7534(24)04054-7. doi: 10.1016/j.annonc.2024.

Read + Share

Amedeo Smart

Independent Medical Education

John A, McDonald F, Popat S. Inoperable Stage III EGFR Mutant Non-Small Cell Lung Cancer: time for drug first, local later? Ann Oncol 2024 Oct 10:S0923-7534(24)04054-7. doi: 10.1016/j.annonc.2024.
PMID: 39395537